SARAH HIGGINBOTHAM: Open Payments
NPI 1710460183 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 45 payments from 13 companies in 2025. Trend: 2023 $284 · 2024 $364 · 2025 $1,252
Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $407 |
| Astellas Pharma US Inc | 8 | $212 |
| AstraZeneca Pharmaceuticals LP | 6 | $169 |
| GlaxoSmithKline, LLC. | 3 | $144 |
| Exact Sciences Corporation | 3 | $86 |
| ABBVIE INC. | 2 | $43 |
| PFIZER INC. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Globus Medical, Inc. | 1 | $29 |
| Lilly USA, LLC | 2 | $28 |
Products named: Wegovy, Veozah, BREZTRI, AREXVY, Cologuard Collection Kit, NURTEC ODT, Kerendia, Rybelsus.
Industry payments across TX — which companies pay providers there.
